Loading clinical trials...
Loading clinical trials...
How to Prevent Lost in Transition? - Adaptive Randomised Controlled Trial of a Self-management Based Survivorship Intervention for Chinese Cancer Survivors
This study, using a sequential multiple assessment randomized controlled trial (SMART) approach, will evaluate a cancer survivorship care intervention on physical symptom distress, weight management, self-efficacy in managing cancer and health-related quality of life among Chinese patients recently completed curative cancer treatment.
This study, using this SMART approach, will assess the effect of a cancer survivorship care intervention on physical symptom distress, self-efficacy in managing cancer, weight management and health-related quality of life among Chinese patients recently completing curative cancer treatment. First, the investigators will test the effect of a one-off, multidisciplinary team face-to-face assessment (namely, the cancer survivorship clinic) with personalized advice on symptom management, lifestyle modification and anxiety management in reducing the case prevalence of symptom distress, increasing the proportion meeting the weight management criteria, and improving self-efficacy and health-related quality of life among cancer survivors in post-treatment survivorship, in comparison to those receiving skills-based pamphlets for symptom management and lifestyle recommendations. Secondly, this study aims to explore if a step-up targeted personalized intervention is more effective for patients who continue to have symptom distress and/or not to meet the weight management criteria if patients have attended cancer survivorship clinic (i.e. the embedded adaptive intervention) in comparison to those receiving skills-based pamphlets.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Kwong Wah Hospital-Breast Center
Hong Kong, Hong Kong
Pamela Youde Nethersole Eastern Hospital-Department of oncology
Hong Kong, Hong Kong
Prince of Wales Hospital-Department of Surgery
Hong Kong, Hong Kong
Queen Mary Hospital-Department of Obstetrics & Gynaecology
Hong Kong, Hong Kong
Queen Mary Hospital-Department of Oncology
Hong Kong, Hong Kong
Queen Mary Hospital-Department of Surgery
Hong Kong, Hong Kong
Tung Wah Hospital-Department of Surgery
Hong Kong, Hong Kong
Start Date
April 12, 2023
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2026
Last Updated
May 13, 2025
486
ESTIMATED participants
Cancer survivorship care intervention
BEHAVIORAL
Step-up targeted personalized intervention
BEHAVIORAL
First stage control intervention
BEHAVIORAL
Second stage control intervention
BEHAVIORAL
Lead Sponsor
The University of Hong Kong
NCT00026884
NCT07213804
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions